Yan Shi
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 79
- Pancreatic and Hepatic Oncology Research 12
- Colorectal Cancer Treatments and Studies 11
-
- Cancer-related molecular mechanisms research 9
- Co-authors
- Lian Leng LowGuanghai DaiLin HuangTieliu ShiChengping WenDuoli XieHuanlong LiuFarhad Fakhrudin Vasanwala
- Journals
- Oncotarget (6 papers)Frontiers in Nutrition (5 papers)Food & Function (4 papers)PLoS ONE (4 papers)The Journal of Immunology (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yan Shi
183 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Oncology 947
- Cancer Research 522
- Otorhinolaryngology 90
- Complementary and alternative medicine 169
- Pharmacology 176
Countries citing papers authored by Yan Shi
This map shows the geographic impact of Yan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Shi more than expected).
Fields of papers citing papers by Yan Shi
This network shows the impact of papers produced by Yan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Shi. The network helps show where Yan Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 5 | |
| 10 | 2019 | 3 | |
| 11 | 2018 | 0 | |
| 12 | 2017 | 19 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 43 | |
| 15 | 2016 | 1 | |
| 16 | 2013 | 5 | |
| 17 | Clinical observation of Jiangtang Wan’s curative effect on metabolic syndrome complicated with impaired glucose regulation in qi-yin deficiency | 2012 | 1 |
| 18 | Effect of Chinese Herbal Compound Yitangkang on PKC Protein Expression of STZ Rats | 2012 | 1 |
| 19 | Effect of Chinese Herbal Compound Yitangkang on Nav1.7 Protein and mRNA Expression in Diabetic Rats | 2012 | 1 |
| 20 | Epidemiological investigation of Lyme disease in parts of forest areas in Qinghai province. | 2009 | 2 |
About Yan Shi
Yan Shi is a scholar working on Oncology, Cancer Research, Otorhinolaryngology, Hepatology and Pulmonary and Respiratory Medicine, having authored 191 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Gastric Cancer Management and Outcomes (15 papers), Salivary Gland Tumors Diagnosis and Treatment (13 papers), Pancreatic and Hepatic Oncology Research (12 papers), RNA modifications and cancer (11 papers), Colorectal Cancer Treatments and Studies (11 papers), Head and Neck Cancer Studies (9 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Oncology (947 citations), Cancer Research (522 citations), Otorhinolaryngology (90 citations), Complementary and alternative medicine (169 citations) and Pharmacology (176 citations). Yan Shi has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lian Leng Low, Guanghai Dai, Lin Huang, Tieliu Shi, Chengping Wen, Duoli Xie, Huanlong Liu, Farhad Fakhrudin Vasanwala, Sher Guan Low and David F. Jarrard. Their work appears in journals such as Oncotarget, Frontiers in Nutrition, Food & Function, PLoS ONE and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.